Metropolitan Bank Holding Corp.

MCB

CIK 0001476034 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$2M
↓-47.3% -$2Mvs FY2024 (Q4)
Operating Income
$2M
↓-47.3% -$2Mvs FY2024 (Q4)
Gross Profit
$2M
↓-47.3% -$2Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
0/100
  • Profitability
    0Insufficient data
  • Liquidity
    0Insufficient data
  • Leverage
    0Insufficient data
  • Efficiency
    0Asset Turnover 0.00x (1.0+ = capital-efficient)
  • Growth
    0Revenue YoY -47.3% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project MCB's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was 1.1%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$115.25
Total enterprise IV
$1.24B
Diluted shares
0.01B
Terminal PV
$872M (70% of total)
Year-5 FCF
$103M
YearProjected FCFDiscounted PV
+1$91M$83M
+2$94M$78M
+3$97M$73M
+4$100M$68M
+5$103M$64M
Terminal$1.40B$872M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
investment in PP&E
Dividends paid (TTM)
$3M
cash returned to holders
Stock buybacks (TTM)
$73M
share count reduction
Stock-based comp (TTM)
$9M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$8.26B
everything owned
Total liabilities
$7.51B
everything owed
Stockholders' equity
$743M
shareholder claim

Recent performance · 41 quarters

Revenue↓-47.3% -$2M
$2M
Net Income↑+34.7% +$7M
$29M
Free Cash Flow↓-63.1% -$53M
$31M

Drill down